Results
4186
Companies which are more than 50% undervalued based on analyst price target.
4,186 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSTR | US$341.25 | -9.6% | 580.9% | US$83.8b | US$524.10 | PS182.3x | E59.7% | n/a | Software | ||
1299 | HK$54.25 | 0.6% | -11.3% | HK$580.3b | HK$93.05 | PE15.4x | E13.7% | 3.0% | Insurance | ||
300760 | CN¥232.40 | 1.3% | -13.4% | CN¥281.1b | CN¥349.64 | PE22.7x | E13.3% | 3.1% | Healthcare | ||
AMMN | Rp7,975.00 | -5.1% | 4.9% | Rp578.3t | Rp12,000.00 | PE39.2x | E-25.7% | n/a | Materials | ||
NPN | R3,902.76 | 5.5% | 22.8% | R653.0b | R5,855.39 | PE10.1x | E19.8% | 0.3% | Retail | ||
A005380 | ₩205,000.00 | -1.9% | -1.4% | ₩45.2t | ₩312,300.69 | PE4x | E5.8% | 5.6% | Automobiles | ||
512599 | ₹2,252.65 | -5.7% | -28.5% | ₹2.6t | ₹4,255.00 | PE48.1x | E33.4% | 0.06% | Capital Goods | ||
ADANIPORTS | ₹1,077.05 | -2.4% | -11.6% | ₹2.3t | ₹1,652.00 | PE23.7x | E12.4% | 0.6% | Transportation | ||
1024 | HK$42.10 | 5.0% | 2.4% | HK$180.0b | HK$66.04 | PE11.2x | E16.7% | n/a | Media | ||
PRU | UK£6.71 | 2.9% | -18.0% | UK£17.7b | UK£11.31 | PE25.1x | E22.8% | 2.5% | Insurance | ||
BIIB | US$144.41 | 1.2% | -41.5% | US$21.2b | US$228.33 | PE13x | E10.3% | n/a | Pharmaceuticals & Biotech | ||
ADANIGREEN | ₹971.85 | -5.7% | -41.7% | ₹1.5t | ₹1,613.00 | PE123.5x | E68.3% | n/a | Utilities | ||
300308 | CN¥114.82 | -13.0% | 56.4% | CN¥126.8b | CN¥196.50 | PE27.4x | E33.1% | 0.3% | Tech | ||
SMMT | US$21.64 | -8.0% | 452.0% | US$17.3b | US$33.08 | PB36.4x | E38.9% | n/a | Pharmaceuticals & Biotech | ||
HEIO | €58.25 | 2.1% | -25.2% | €16.6b | €104.00 | PE30.7x | n/a | 3.0% | Food, Beverage & Tobacco | ||
MRNA | US$40.72 | 5.8% | -59.7% | US$17.3b | US$63.64 | PS3.1x | E22.5% | n/a | Pharmaceuticals & Biotech | ||
FSLR | US$166.01 | -3.4% | 13.5% | US$17.2b | US$267.53 | PE14.2x | E24.3% | n/a | Semiconductors | ||
VWS | DKK 101.35 | 6.5% | -48.1% | DKK 98.8b | DKK 160.26 | PE279.6x | E35.7% | n/a | Capital Goods | ||
A005490 | ₩261,500.00 | 0.8% | -40.2% | ₩19.7t | ₩401,285.71 | PE14.9x | E23.3% | 3.8% | Materials | ||
RECLTD | ₹440.35 | -5.0% | -10.9% | ₹1.2t | ₹672.09 | PE7.8x | E11.9% | 4.5% | Diversified Financials | ||
A196170 | ₩362,000.00 | 4.3% | 407.0% | ₩19.3t | ₩565,000.00 | PS259.4x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
A028260 | ₩115,000.00 | -0.5% | -22.7% | ₩18.9t | ₩175,941.18 | PE9x | E10.7% | 2.2% | Capital Goods | ||
A051910 | ₩239,500.00 | -0.4% | -44.3% | ₩18.0t | ₩450,857.14 | PS0.4x | E53.7% | 1.5% | Materials | ||
GMAB | DKK 1,410.00 | -6.7% | -26.2% | DKK 88.6b | DKK 2,292.13 | PE19x | E21.4% | n/a | Pharmaceuticals & Biotech |